PRQR:NASDAQ
ProQR Therapeutics NV
$1.34
arrow_upward
+1.91%(+0.025) 1D
Oct 19, 11:16:56 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PRQR...
Open
$1.35
High
$1.37
Low
$1.32
Mkt. cap
188.40M
Avg. vol.
747.32K
Volume
347.29K
52-wk high
$3.10
52-wk low
$1.30
EPS
-$0.44
Beta
0.20
Shares outstanding
138.09M
No. of employees
187
Open
$1.35
High
$1.37
Low
$1.32
Mkt. cap
188.40M
Avg. vol.
747.32K
Volume
347.29K
52-wk high
$3.10
52-wk low
$1.30
EPS
-$0.44
Beta
0.20
Shares outstanding
138.09M
No. of employees
187
News stories
From web sources and news partners
https://www.dars.gov.et/
·
4 weeks ago
PRQR Q2 2026 Earnings: Narrower-Than-Expected Loss Beats Consensus by 31% - Buyback Announcement Report
Profile
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia
About ProQR Therapeutics NV